Vanguard Group Inc Protara Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TARA
# of Institutions
40Shares Held
4.55MCall Options Held
102KPut Options Held
18.2K-
Opaleye Management Inc. Boston, MA2.69MShares$5.47 Million2.63% of portfolio
-
Boxer Capital, LLC San Diego, CA209KShares$424,7300.04% of portfolio
-
Ikarian Capital, LLC Dallas, TX203KShares$411,4830.11% of portfolio
-
Baker Bros. Advisors LP New York, NY200KShares$405,3320.01% of portfolio
-
Stem Point Capital LP New York, NY168KShares$341,9370.18% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $22.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...